Cannabis in oral medicine: what should we know? — a narrative review

Yesica Lorena Castillo-García; Diana Sofia Pedraza-Alonso; Juan Pablo Rodríguez-Mora

doi:10.5327/2525-5711.388

Authors

Yesica Lorena Castillo-García School of Dentistry, Universidad Nacional de Colombia, Sede Bogotá — Bogotá, Colombia. https://orcid.org/0009-0007-7641-6538
Diana Sofia Pedraza-Alonso School of Dentistry, Universidad Nacional de Colombia, Sede Bogotá — Bogotá, Colombia. https://orcid.org/0009-0008-0440-9897
Juan Pablo Rodríguez-Mora School of Dentistry, Universidad Nacional de Colombia, Sede Bogotá — Bogotá, Colombia. https://orcid.org/0009-0009-3198-1861

DOI:

https://doi.org/10.5327/2525-5711.388

Keywords:

Cannabinoid, Endocannabinoid system, Marijuana, Oral health, Systemic health

Abstract

Cannabis sativa, commonly known as cannabis or marijuana, is one of the most widely used psychoactive substances worldwide, according to the 2022 World Drug Report by the United Nations Office on Drugs and Crime. The growing global movement toward legalization is driven primarily by the plant’s potential medical and industrial benefits, rather than its recreational use. However, there is still a significant lack of understanding about its chemical composition, mechanisms of action, and physiological effects on the human body. This knowledge gap presents an ongoing challenge for healthcare providers. This narrative review compiles current scientific evidence from databases such as PubMed, SciELO, Scopus, and Google Scholar, focusing on the biological and physiological aspects of cannabis use and its implications in the context of oral medicine. Given the rapid expansion of cannabis-related research and its implications across multiple areas of healthcare, this review provides valuable clinical and scientific insights for healthcare professionals, researchers, and policymakers working in both oral and systemic health.

References

Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219-27. https://doi.org/10.1056/NEJMra1402309

United Nations Office on Drugs and Crime. World Drug Report 2022. Vienna: UNODC; 2022.

Schurman LD, Lu D, Kendall DA, Howlett AC, Lichtman AH. Molecular mechanism and cannabinoid pharmacology. In: Nader M, Hurd Y, eds. Substance use disorders. Handbook of experimental pharmacology. Nova York: Springer International Publishing; 2019. p. 323-53. https://doi.org/10.1007/164_2019_298

Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19. https://doi.org/10.3389/fpls.2016.00019

Childers SR, Breivogel CS. Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend. 1998;51(1-2):173-87. https://doi.org/10.1016/s0376-8716(98)00075-1

Dinis-Oliveira RJ. Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity. Drug Metab Rev. 2016;48(1):80-7. https://doi.org/10.3109/03602532.2015.1137307

Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review. BMC Psychiatry. 2020;20(1):24. https://doi.org/10.1186/s12888-019-2409-8

Gülck T, Møller BL. Phytocannabinoids: origins and biosynthesis. Trends Plant Sci. 2020;25(10):985-1004. https://doi.org/10.1016/j.tplants.2020.05.005

Fisar Z. Phytocannabinoids and endocannabinoids. Curr Drug Abuse Rev. 2009;2(1):51-75. https://doi.org/10.2174/1874473710902010051

Castillo-Arellano J, Canseco-Alba A, Cutler SJ, León F. The polypharmacological effects of cannabidiol. Molecules. 2023;28(7):3271. https://doi.org/10.3390/molecules28073271

Peng J, Fan M, An C, Ni F, Huang W, Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol. 2022;130(4):439-56. https://doi.org/10.1111/bcpt.13710

Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The endocannabinoid system: a potential target for the treatment of various diseases. Int J Mol Sci. 2021;22(17):9472. https://doi.org/10.3390/ijms22179472

Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008;20 Suppl 1:10-4. https://doi.org/10.1111/j.1365-2826.2008.01671.x

Brust CA, Swanson MA, Bohn LM. Structural and functional insights into the G protein-coupled receptors: CB1 and CB2. Biochem Soc Trans. 2023;51(4):1533-43. https://doi.org/10.1042/BST20221316

Joshi N, Onaivi ES. Endocannabinoid system components: overview and tissue distribution. In: Bukiya A, ed. Recent advances in cannabinoid physiology and pathology. Advances in experimental medicine and biology. Nova York: Springer International Publishing; 2019. p. 1-12. https://doi.org/10.1007/978-3-030-21737-2_1

Biringer RG. The rise and fall of anandamide: processes that control synthesis, degradation, and storage. Mol Cell Biochem. 2021;476(7):2753-75. https://doi.org/10.1007/s11010-021-04121-5

Martín Giménez VM, Noriega SE, Kassuha DE, Fuentes LB, Manucha W. Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease. Ther Adv Cardiovasc Dis. 2018;12(7):177-90. https://doi.org/10.1177/1753944718773690

Grossman S, Tan H, Gadiwalla Y. Cannabis and orofacial pain: a systematic review. Br J Oral Maxillofac Surg. 2022;60(5):e677-90. https://doi.org/10.1016/j.bjoms.2021.06.005

Longworth J, Szafron M, Gruza A, Silva K. Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: a scoping review. Dent Rev. 2023;3(1):100063. https://doi.org/10.1016/j.dentre.2023.100063

McDonough P, McKenna JP, McCreary C, Downer EJ. Neuropathic orofacial pain: cannabinoids as a therapeutic avenue. Int J Biochem Cell Biol. 2014;55:72-8. https://doi.org/10.1016/j.biocel.2014.08.007

Votrubec C, Tran P, Lei A, Brunet Z, Bean L, Olsen BW, Sharma D. Cannabinoid therapeutics in orofacial pain management: a systematic review. Aust Dent J. 2022;67(4):314-27. https://doi.org/10.1111/adj.12934

Hill KP, Palastro MD, Johnson B, Ditre JW. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017;2(1):96-104. https://doi.org/10.1089/can.2017.0017

Cuba LF, Salum FG, Cherubini K, Figueiredo MAZ. Cannabidiol: an alternative therapeutic agent for oral mucositis? J Clin Pharm Ther. 2017;42(3):245-50. https://doi.org/10.1111/jcpt.12504

Gambino A, Cabras M, Panagiotakos E, Calvo F, Macciotta A, Cafaro A, et al. Evaluating the suitability and potential efficiency of cannabis sativa oil for patients with primary burning mouth syndrome: a prospective, open-label, single-arm pilot study. Pain Med. 2021;22(1):142-51. https://doi.org/10.1093/pm/pnaa318

Elliott DA, Nabavizadeh N, Romer JL, Chen Y, Holland JM. Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy. Support Care Cancer. 2016;24(8):3517-24. https://doi.org/10.1007/s00520-016-3180-8

Habib G, Steinberg D, Jabbour A. The impact of medical cannabis consumption on the oral flora and saliva. PLoS One. 2021;16(2):e0247044. https://doi.org/10.1371/journal.pone.0247044

Liu C, Qi X, Yang D, Neely A, Zhou Z. The effects of cannabis use on oral health. Oral Dis. 2020;26(7):1366-74. https://doi.org/10.1111/odi.13246

Joshi S, Ashley M. Cannabis: a joint problem for patients and the dental profession. Br Dent J. 2016;220(11):597-601. https://doi.org/10.1038/sj.bdj.2016.416

Cho C, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J. 2005;50(2):70-4. https://doi.org/10.1111/j.1834-7819.2005.tb00343.x

Sordi MB, Massochin RC, Camargo AR, Lemos T, Munhoz EA. Oral health assessment for users of marijuana and cocaine/crack substances. Braz Oral Res. 2017;31:e102. https://doi.org/10.1590/1807-3107BOR-2017.vol31.0102

Bellocchio L, Inchingolo AD, Inchingolo AM, Lorusso F, Malcangi G, Santacroce L, et al. Cannabinoids drugs and oral health–from recreational side-effects to medicinal purposes: a systematic review. Int J Mol Sci. 2021;22(15):8329. https://doi.org/10.3390/ijms22158329

Carmona Rendón Y, Santiago Garzón H, Bueno-Silva B, Arce RM, Suárez LJ. Cannabinoids in periodontology: where are we now? Antibiotics (Basel). 2023;12(12):1687. https://doi.org/10.3390/antibiotics12121687

Pellegrini G, Carmagnola D, Toma M, Rasperini G, Orioli M, Dellavia C. Involvement of the endocannabinoid system in current and recurrent periodontitis: a human study. J Periodontal Res. 2023;58(2):422-32. https://doi.org/10.1111/jre.13103

Gu Z, Singh S, Niyogi RG, Lamont GJ, Wang H, Lamont RJ, et al. Marijuana-derived cannabinoids trigger a CB2/PI3K axis of suppression of the innate response to oral pathogens. Front Immunol. 2019;10:2288. https://doi.org/10.3389/fimmu.2019.02288

Bellocchio L, Patano A, Inchingolo AD, Inchingolo F, Dipalma G, Isacco CG, et al. Cannabidiol for oral health: a new promising therapeutical tool in dentistry. Int J Mol Sci. 2023;24(11):9693. https://doi.org/10.3390/ijms24119693

Mateos-Moreno MV, Del-Río-Highsmith NA, Riobóo-García R, Solá-Ruiz MF, Celemín-Viñuela A. Dental profile of a community of recovering drug addicts: biomedical aspects. Retrospective cohort study. Med Oral Patol Oral Cir Bucal. 2013;18(4):e671-9. https://doi.org/10.4317/medoral.18669

Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res. 2004;64(11):4049-54. https://doi.org/10.1158/0008-5472.CAN-03-3425

Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya KAAS. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol. 2003;39(2):106-14. https://doi.org/10.1016/s1368-8375(02)00026-x

Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol. 2004;40(3):304-13. https://doi.org/10.1016/j.oraloncology.2003.08.015

Shekarchizadeh H, Khami MR, Mohebbi SZ, Ekhtiari H, Virtanen JI. Oral health of drug abusers: a review of health effects and care. Iran J Public Health. 2013;42(9):929-40. PMID: 26060654.

Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Marshall JR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999;8(12):1071-8. PMID: 10613339.

Cretu B, Zamfir A, Bucurica S, Scheau AE, Fiedler IS, Caruntu C, et al. Role of cannabinoids in oral cancer. Int J Mol Sci. 2024;25(2):969. https://doi.org/10.3390/ijms25020969